Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP361786.RAu_W76cWPBI4iOHfRU_7RLHmOiwO98elIY6BC-dp0liU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP361786.RAu_W76cWPBI4iOHfRU_7RLHmOiwO98elIY6BC-dp0liU130_assertion type Assertion NP361786.RAu_W76cWPBI4iOHfRU_7RLHmOiwO98elIY6BC-dp0liU130_head.
- NP361786.RAu_W76cWPBI4iOHfRU_7RLHmOiwO98elIY6BC-dp0liU130_assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP361786.RAu_W76cWPBI4iOHfRU_7RLHmOiwO98elIY6BC-dp0liU130_provenance.
- NP361786.RAu_W76cWPBI4iOHfRU_7RLHmOiwO98elIY6BC-dp0liU130_assertion evidence source_evidence_literature NP361786.RAu_W76cWPBI4iOHfRU_7RLHmOiwO98elIY6BC-dp0liU130_provenance.
- NP361786.RAu_W76cWPBI4iOHfRU_7RLHmOiwO98elIY6BC-dp0liU130_assertion SIO_000772 14607763 NP361786.RAu_W76cWPBI4iOHfRU_7RLHmOiwO98elIY6BC-dp0liU130_provenance.
- NP361786.RAu_W76cWPBI4iOHfRU_7RLHmOiwO98elIY6BC-dp0liU130_assertion wasDerivedFrom befree-20140225 NP361786.RAu_W76cWPBI4iOHfRU_7RLHmOiwO98elIY6BC-dp0liU130_provenance.
- NP361786.RAu_W76cWPBI4iOHfRU_7RLHmOiwO98elIY6BC-dp0liU130_assertion wasGeneratedBy ECO_0000203 NP361786.RAu_W76cWPBI4iOHfRU_7RLHmOiwO98elIY6BC-dp0liU130_provenance.